Celldex Therapeutics, Inc. (CLDX) Revenue 2016–2025
Celldex Therapeutics, Inc. (CLDX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.5MFY2025 · since FY2016: $6.8M → $1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5M | -78.0% |
| FY2024 | $7.0M | +2.0% |
| FY2023 | $6.9M | +192.0% |
| FY2022 | $2.4M | -49.3% |
| FY2021 | $4.7M | -37.3% |
| FY2020 | $7.4M | +107.6% |
| FY2019 | $3.6M | -62.5% |
| FY2018 | $9.5M | -25.2% |
| FY2017 | $12.7M | +87.8% |
| FY2016 | $6.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice